BWM
ABBV icon

Birchcreek Wealth Management’s AbbVie ABBV Stock Holding History

Birchcreek Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
1,719
+100
+6% +$22.2K 0.18% 81
2025
Q4 		$370K Hold
1,619
– – 0.18% 79
2025
Q3 		$375K Sell
1,619
-196
-11% -$39.9K 0.19% 82
2025
Q2 		$337K Hold
1,815
– – 0.19% 85
2025
Q1 		$380K Hold
1,815
– – 0.24% 79
2024
Q4 		$323K Hold
1,815
– – 0.2% 94
2024
Q3 		$358K Sell
1,815
-345
-16% -$64.4K 0.23% 81
2024
Q2 		$370K Sell
2,160
-400
-16% -$66.3K 0.21% 94
2024
Q1 		$466K Buy
2,560
+100
+4% +$17.2K 0.25% 88
2023
Q4 		$381K Sell
2,460
-52
-2% -$7.58K 0.23% 95
2023
Q3 		$374K Sell
2,512
-134
-5% -$19.7K 0.25% 90
2023
Q2 		$356K Sell
2,646
-323
-11% -$47.4K 0.25% 96
2023
Q1 		$473K Buy
2,969
+452
+18% +$69.1K 0.37% 70
2022
Q4 		$407K Hold
2,517
– – 0.36% 71
2022
Q3 		$338K Buy
2,517
+384
+18% +$55.1K 0.31% 73
2022
Q2 		$327K Buy
2,133
+528
+33% +$80.7K 0.29% 77
2022
Q1 		$260K Buy
+1,605
New +$233K 0.23% 96
2021
Q1 		– Sell
-1,320
Closed -$141K – 110
2020
Q4 		$141K Buy
+1,320
New +$127K 0.14% 125

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Birchcreek Wealth Management's ABBV Position: Q1 2026 in Review

Birchcreek Wealth Management increased its AbbVie (ABBV) stake by 6.2% in Q1 2026, buying an estimated $22.2K and bringing the position to 1,719 shares worth $374K. The position accounts for 0.18% of the portfolio, ranked #81.

Birchcreek Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. The position peaked at $473K in Q1 2023. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Birchcreek Wealth Management held 1,719 shares of AbbVie worth $374K as of Q1 2026.
  • Birchcreek Wealth Management bought 100 AbbVie shares in Q1 2026, an estimated $22.2K.
  • AbbVie made up 0.18% of Birchcreek Wealth Management's portfolio in Q1 2026, its #81 holding.
  • Birchcreek Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
  • Birchcreek Wealth Management's AbbVie position peaked at $473K in Q1 2023.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Birchcreek Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.